| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA Interference | 17 | 2017 | 378 | 1.960 |
Why?
|
| RNA, Small Interfering | 12 | 2016 | 557 | 1.440 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2021 | 613 | 1.320 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 3 | 2020 | 105 | 1.300 |
Why?
|
| Receptors, Androgen | 5 | 2020 | 119 | 1.230 |
Why?
|
| Oncogene Proteins | 2 | 2018 | 64 | 1.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2020 | 122 | 0.920 |
Why?
|
| Genomics | 6 | 2020 | 793 | 0.830 |
Why?
|
| Multiprotein Complexes | 3 | 2019 | 96 | 0.820 |
Why?
|
| Sarcoma, Ewing | 1 | 2022 | 42 | 0.810 |
Why?
|
| Cell Division | 4 | 2008 | 692 | 0.800 |
Why?
|
| DNA Replication | 2 | 2019 | 172 | 0.790 |
Why?
|
| Glioblastoma | 5 | 2025 | 269 | 0.790 |
Why?
|
| Lentivirus | 1 | 2021 | 43 | 0.750 |
Why?
|
| DNA Damage | 2 | 2020 | 374 | 0.740 |
Why?
|
| Cell Line, Tumor | 14 | 2025 | 2615 | 0.740 |
Why?
|
| Plicamycin | 2 | 2020 | 9 | 0.740 |
Why?
|
| DNA Repair | 2 | 2020 | 363 | 0.740 |
Why?
|
| Endoribonucleases | 4 | 2007 | 94 | 0.730 |
Why?
|
| Transcription Factors | 9 | 2023 | 1671 | 0.710 |
Why?
|
| Drug Discovery | 1 | 2021 | 110 | 0.690 |
Why?
|
| Lung Neoplasms | 5 | 2021 | 2380 | 0.690 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2019 | 4 | 0.680 |
Why?
|
| Genetic Vectors | 2 | 2021 | 448 | 0.680 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2020 | 111 | 0.670 |
Why?
|
| DNA Helicases | 1 | 2019 | 85 | 0.650 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 4 | 2021 | 1132 | 0.620 |
Why?
|
| Biomarkers, Tumor | 4 | 2021 | 1559 | 0.610 |
Why?
|
| PPAR gamma | 2 | 2018 | 73 | 0.610 |
Why?
|
| Gene Expression Regulation, Neoplastic | 9 | 2022 | 1295 | 0.580 |
Why?
|
| Tripartite Motif Proteins | 1 | 2016 | 3 | 0.550 |
Why?
|
| Antineoplastic Agents | 6 | 2021 | 2347 | 0.530 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2021 | 1374 | 0.530 |
Why?
|
| Carrier Proteins | 1 | 2019 | 679 | 0.520 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 175 | 0.490 |
Why?
|
| Prostatic Neoplasms | 3 | 2016 | 1757 | 0.460 |
Why?
|
| Mutation | 5 | 2021 | 4203 | 0.450 |
Why?
|
| Protease Inhibitors | 1 | 2014 | 72 | 0.440 |
Why?
|
| Ubiquitin Thiolesterase | 3 | 2022 | 66 | 0.440 |
Why?
|
| HeLa Cells | 10 | 2016 | 516 | 0.440 |
Why?
|
| Endopeptidases | 1 | 2014 | 118 | 0.430 |
Why?
|
| Humans | 55 | 2025 | 91073 | 0.430 |
Why?
|
| Chromatin | 5 | 2023 | 410 | 0.410 |
Why?
|
| Cellular Senescence | 2 | 2025 | 101 | 0.410 |
Why?
|
| Gene Regulatory Networks | 3 | 2023 | 309 | 0.410 |
Why?
|
| Genome, Human | 5 | 2017 | 794 | 0.400 |
Why?
|
| Animals | 33 | 2025 | 27783 | 0.390 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 494 | 0.380 |
Why?
|
| Gene Library | 4 | 2008 | 133 | 0.380 |
Why?
|
| Nuclear Proteins | 4 | 2019 | 731 | 0.380 |
Why?
|
| Mice | 18 | 2025 | 11993 | 0.320 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2022 | 134 | 0.320 |
Why?
|
| Mammals | 2 | 2008 | 244 | 0.320 |
Why?
|
| Cell Proliferation | 9 | 2025 | 1695 | 0.320 |
Why?
|
| Chromosomes, Artificial, Bacterial | 2 | 2008 | 30 | 0.320 |
Why?
|
| Neoplasms | 3 | 2021 | 3053 | 0.320 |
Why?
|
| Glioma | 2 | 2023 | 295 | 0.310 |
Why?
|
| Transcription, Genetic | 4 | 2021 | 1163 | 0.300 |
Why?
|
| Systems Biology | 1 | 2008 | 44 | 0.300 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 2013 | 135 | 0.290 |
Why?
|
| Ribonuclease III | 2 | 2016 | 16 | 0.290 |
Why?
|
| Genomic Library | 1 | 2007 | 33 | 0.280 |
Why?
|
| Ubiquitination | 3 | 2016 | 76 | 0.270 |
Why?
|
| Estrogen Receptor alpha | 3 | 2020 | 148 | 0.270 |
Why?
|
| Breast Neoplasms | 6 | 2021 | 3029 | 0.270 |
Why?
|
| Chromosomes, Human, Y | 2 | 2004 | 24 | 0.270 |
Why?
|
| Drosophila melanogaster | 6 | 2019 | 615 | 0.260 |
Why?
|
| Homeodomain Proteins | 4 | 2014 | 558 | 0.260 |
Why?
|
| RNA, Double-Stranded | 1 | 2005 | 23 | 0.250 |
Why?
|
| Transcriptional Regulator ERG | 2 | 2016 | 17 | 0.250 |
Why?
|
| Enzyme Inhibitors | 2 | 2019 | 652 | 0.250 |
Why?
|
| Baculoviral IAP Repeat-Containing 3 Protein | 1 | 2025 | 2 | 0.250 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2025 | 34 | 0.240 |
Why?
|
| Genes, Essential | 1 | 2004 | 20 | 0.240 |
Why?
|
| Centrosome | 3 | 2009 | 22 | 0.240 |
Why?
|
| Spindle Apparatus | 4 | 2009 | 65 | 0.230 |
Why?
|
| Pediculus | 1 | 2003 | 3 | 0.220 |
Why?
|
| Clothing | 1 | 2003 | 7 | 0.220 |
Why?
|
| Cell Nucleus | 2 | 2023 | 607 | 0.210 |
Why?
|
| Mice, SCID | 4 | 2020 | 260 | 0.210 |
Why?
|
| Stem Cells | 2 | 2017 | 381 | 0.210 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2022 | 3 | 0.210 |
Why?
|
| Hepacivirus | 1 | 2004 | 132 | 0.210 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2022 | 8 | 0.210 |
Why?
|
| RNA, Viral | 1 | 2004 | 320 | 0.210 |
Why?
|
| Virus Replication | 1 | 2004 | 327 | 0.200 |
Why?
|
| Heart Conduction System | 1 | 2023 | 117 | 0.200 |
Why?
|
| Genetics, Population | 3 | 2010 | 413 | 0.200 |
Why?
|
| Brain Neoplasms | 2 | 2019 | 784 | 0.200 |
Why?
|
| Gamma Rays | 1 | 2021 | 73 | 0.190 |
Why?
|
| Myocardial Contraction | 1 | 2023 | 252 | 0.190 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2021 | 10 | 0.190 |
Why?
|
| Mice, Inbred NOD | 3 | 2020 | 200 | 0.190 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2021 | 20 | 0.190 |
Why?
|
| Drosophila Proteins | 4 | 2017 | 511 | 0.190 |
Why?
|
| Receptors, Retinoic Acid | 2 | 2013 | 48 | 0.190 |
Why?
|
| Evolution, Molecular | 3 | 2004 | 859 | 0.180 |
Why?
|
| Gene Expression | 2 | 2021 | 1313 | 0.180 |
Why?
|
| Protein Binding | 5 | 2016 | 1508 | 0.180 |
Why?
|
| Binding Sites | 5 | 2017 | 1127 | 0.180 |
Why?
|
| Recombination, Genetic | 1 | 2003 | 447 | 0.180 |
Why?
|
| Molecular Sequence Data | 5 | 2006 | 3031 | 0.180 |
Why?
|
| Male | 14 | 2020 | 43249 | 0.180 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2020 | 9 | 0.180 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2020 | 21 | 0.180 |
Why?
|
| Thrombospondin 1 | 1 | 2020 | 21 | 0.170 |
Why?
|
| Structure-Activity Relationship | 1 | 2021 | 429 | 0.170 |
Why?
|
| DNA | 2 | 2006 | 1313 | 0.170 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 2 | 2017 | 4 | 0.170 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2022 | 455 | 0.170 |
Why?
|
| Tamoxifen | 1 | 2020 | 167 | 0.170 |
Why?
|
| Peptide Hydrolases | 1 | 2019 | 100 | 0.170 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 925 | 0.160 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2009 | 184 | 0.160 |
Why?
|
| Genomic Instability | 1 | 2019 | 84 | 0.160 |
Why?
|
| Fertility | 1 | 2019 | 116 | 0.160 |
Why?
|
| Gene Expression Profiling | 4 | 2017 | 1465 | 0.160 |
Why?
|
| Radiation Tolerance | 1 | 2019 | 173 | 0.160 |
Why?
|
| Molecular Structure | 1 | 2019 | 304 | 0.160 |
Why?
|
| Proteolysis | 2 | 2016 | 118 | 0.160 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2019 | 67 | 0.160 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2019 | 95 | 0.160 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2018 | 20 | 0.160 |
Why?
|
| Microsatellite Repeats | 3 | 2004 | 148 | 0.150 |
Why?
|
| Adiposity | 1 | 2018 | 76 | 0.150 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 138 | 0.150 |
Why?
|
| Cytogenetic Analysis | 1 | 2018 | 71 | 0.150 |
Why?
|
| Cell Differentiation | 2 | 2015 | 1564 | 0.150 |
Why?
|
| Base Sequence | 4 | 2006 | 2329 | 0.150 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 483 | 0.140 |
Why?
|
| Phenylthiohydantoin | 1 | 2017 | 47 | 0.140 |
Why?
|
| Nitriles | 2 | 2017 | 157 | 0.140 |
Why?
|
| Transfection | 3 | 2016 | 910 | 0.140 |
Why?
|
| Bridged-Ring Compounds | 1 | 2017 | 14 | 0.140 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2017 | 14 | 0.140 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 264 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 1935 | 0.140 |
Why?
|
| Lysine | 1 | 2018 | 181 | 0.140 |
Why?
|
| Oligodendrocyte Transcription Factor 2 | 1 | 2017 | 5 | 0.140 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2017 | 21 | 0.140 |
Why?
|
| Neoplastic Stem Cells | 2 | 2019 | 163 | 0.140 |
Why?
|
| Models, Molecular | 1 | 2021 | 1327 | 0.140 |
Why?
|
| MCF-7 Cells | 2 | 2017 | 117 | 0.140 |
Why?
|
| HEK293 Cells | 2 | 2016 | 660 | 0.140 |
Why?
|
| Taxoids | 1 | 2017 | 125 | 0.140 |
Why?
|
| Androgen Antagonists | 1 | 2017 | 139 | 0.140 |
Why?
|
| Cytokinesis | 2 | 2009 | 57 | 0.130 |
Why?
|
| Forkhead Transcription Factors | 1 | 2017 | 173 | 0.130 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 424 | 0.130 |
Why?
|
| Carboplatin | 1 | 2017 | 325 | 0.130 |
Why?
|
| Mitosis | 2 | 2008 | 152 | 0.130 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2017 | 153 | 0.130 |
Why?
|
| Serine Endopeptidases | 1 | 2016 | 147 | 0.130 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2015 | 28 | 0.130 |
Why?
|
| RNA, Nuclear | 1 | 2015 | 3 | 0.120 |
Why?
|
| Microscopy, Video | 2 | 2005 | 35 | 0.120 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2016 | 113 | 0.120 |
Why?
|
| Fuchs' Endothelial Dystrophy | 1 | 2015 | 12 | 0.120 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2015 | 24 | 0.120 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2015 | 53 | 0.120 |
Why?
|
| Trimetazidine | 1 | 2014 | 4 | 0.120 |
Why?
|
| Lipid Peroxidation | 1 | 2014 | 45 | 0.120 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2014 | 10 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 493 | 0.120 |
Why?
|
| Protein Interaction Maps | 1 | 2014 | 51 | 0.120 |
Why?
|
| Signal Transduction | 4 | 2014 | 3442 | 0.120 |
Why?
|
| Intestines | 1 | 2017 | 419 | 0.120 |
Why?
|
| Retinoblastoma Protein | 1 | 2014 | 64 | 0.110 |
Why?
|
| Cyanoacrylates | 1 | 2014 | 5 | 0.110 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2014 | 68 | 0.110 |
Why?
|
| Thiazolidinediones | 1 | 2014 | 74 | 0.110 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 282 | 0.110 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2017 | 175 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 79 | 0.110 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2014 | 14 | 0.110 |
Why?
|
| Genome | 4 | 2019 | 395 | 0.110 |
Why?
|
| Phosphorylation | 2 | 2014 | 1131 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2010 | 2440 | 0.110 |
Why?
|
| Fatty Acids | 1 | 2014 | 141 | 0.110 |
Why?
|
| beta Catenin | 1 | 2015 | 267 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2020 | 492 | 0.110 |
Why?
|
| Brain | 2 | 2021 | 2327 | 0.110 |
Why?
|
| Telomere-Binding Proteins | 1 | 2013 | 14 | 0.110 |
Why?
|
| Insulin | 1 | 2018 | 1161 | 0.110 |
Why?
|
| Protein Kinases | 1 | 2014 | 212 | 0.110 |
Why?
|
| Transplantation, Heterologous | 1 | 2014 | 368 | 0.110 |
Why?
|
| PPAR delta | 1 | 2013 | 3 | 0.110 |
Why?
|
| Neuregulin-1 | 1 | 2012 | 16 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 316 | 0.100 |
Why?
|
| Telomerase | 1 | 2013 | 67 | 0.100 |
Why?
|
| Receptor, ErbB-3 | 1 | 2012 | 19 | 0.100 |
Why?
|
| Melanoma | 1 | 2017 | 475 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 3 | 2021 | 1049 | 0.100 |
Why?
|
| Telomere | 1 | 2013 | 119 | 0.100 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2015 | 333 | 0.100 |
Why?
|
| Pyridines | 1 | 2014 | 304 | 0.100 |
Why?
|
| Obesity | 1 | 2018 | 989 | 0.100 |
Why?
|
| Transgenes | 2 | 2011 | 185 | 0.100 |
Why?
|
| DNA Primers | 2 | 2003 | 546 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2016 | 568 | 0.090 |
Why?
|
| Phenotype | 3 | 2014 | 2480 | 0.090 |
Why?
|
| Genetic Therapy | 2 | 2004 | 375 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 526 | 0.090 |
Why?
|
| Female | 12 | 2021 | 47186 | 0.090 |
Why?
|
| Climate | 1 | 2010 | 60 | 0.090 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 1993 | 0.090 |
Why?
|
| Alternative Splicing | 2 | 2017 | 214 | 0.080 |
Why?
|
| Body Patterning | 1 | 2011 | 216 | 0.080 |
Why?
|
| Kinetochores | 1 | 2009 | 7 | 0.080 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2009 | 16 | 0.080 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2011 | 289 | 0.080 |
Why?
|
| Protein Subunits | 1 | 2009 | 123 | 0.080 |
Why?
|
| Astrocytes | 2 | 2021 | 143 | 0.080 |
Why?
|
| Embryonic Stem Cells | 1 | 2009 | 82 | 0.080 |
Why?
|
| Gene Silencing | 2 | 2009 | 178 | 0.080 |
Why?
|
| Gene Frequency | 3 | 2010 | 694 | 0.080 |
Why?
|
| Time Factors | 4 | 2010 | 5378 | 0.070 |
Why?
|
| Quality Control | 1 | 2008 | 117 | 0.070 |
Why?
|
| Adaptation, Physiological | 1 | 2010 | 320 | 0.070 |
Why?
|
| Embryo, Mammalian | 2 | 2009 | 223 | 0.070 |
Why?
|
| Genotype | 3 | 2015 | 1858 | 0.070 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2008 | 60 | 0.070 |
Why?
|
| Untranslated Regions | 1 | 2007 | 18 | 0.070 |
Why?
|
| Genetic Variation | 2 | 2004 | 1384 | 0.070 |
Why?
|
| Germ Cells | 2 | 2019 | 130 | 0.070 |
Why?
|
| Neoplasm Grading | 2 | 2019 | 376 | 0.070 |
Why?
|
| ErbB Receptors | 2 | 2021 | 499 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2023 | 591 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 2375 | 0.060 |
Why?
|
| User-Computer Interface | 1 | 2007 | 187 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 751 | 0.060 |
Why?
|
| Saliva | 1 | 2006 | 125 | 0.060 |
Why?
|
| Estrogens | 2 | 2020 | 200 | 0.060 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2005 | 18 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 888 | 0.060 |
Why?
|
| Disease-Free Survival | 2 | 2017 | 1169 | 0.060 |
Why?
|
| Genetic Techniques | 1 | 2005 | 73 | 0.060 |
Why?
|
| Radiation, Ionizing | 1 | 2025 | 124 | 0.060 |
Why?
|
| Replicon | 1 | 2004 | 7 | 0.060 |
Why?
|
| Embryo Culture Techniques | 1 | 2004 | 9 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 2416 | 0.060 |
Why?
|
| CHO Cells | 2 | 2015 | 189 | 0.060 |
Why?
|
| Genome, Viral | 1 | 2004 | 82 | 0.060 |
Why?
|
| Heat-Shock Proteins | 1 | 2005 | 183 | 0.060 |
Why?
|
| Lice Infestations | 1 | 2003 | 3 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2016 | 137 | 0.050 |
Why?
|
| History, Ancient | 1 | 2003 | 76 | 0.050 |
Why?
|
| Cricetinae | 2 | 2015 | 560 | 0.050 |
Why?
|
| Africa | 1 | 2003 | 102 | 0.050 |
Why?
|
| Histones | 2 | 2017 | 345 | 0.050 |
Why?
|
| Germany | 1 | 2003 | 74 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2004 | 363 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2005 | 511 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 3303 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2003 | 189 | 0.050 |
Why?
|
| Nucleic Acid Conformation | 1 | 2004 | 345 | 0.050 |
Why?
|
| Cell Lineage | 2 | 2017 | 296 | 0.050 |
Why?
|
| Proteins | 1 | 2008 | 800 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2017 | 520 | 0.050 |
Why?
|
| Cell Survival | 1 | 2004 | 984 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 2020 | 0.050 |
Why?
|
| Microchemistry | 1 | 2002 | 6 | 0.050 |
Why?
|
| Templates, Genetic | 1 | 2002 | 34 | 0.050 |
Why?
|
| Haplotypes | 1 | 2004 | 639 | 0.050 |
Why?
|
| DNA-Binding Proteins | 3 | 2016 | 1248 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 2785 | 0.050 |
Why?
|
| Aniline Compounds | 1 | 2021 | 60 | 0.050 |
Why?
|
| Dihydrotestosterone | 1 | 2020 | 28 | 0.050 |
Why?
|
| Aromatase Inhibitors | 1 | 2020 | 29 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2004 | 490 | 0.040 |
Why?
|
| Estradiol | 1 | 2020 | 250 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2003 | 1079 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2005 | 962 | 0.040 |
Why?
|
| Linear Energy Transfer | 1 | 2019 | 5 | 0.040 |
Why?
|
| Cell Line | 2 | 2018 | 2506 | 0.040 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2019 | 50 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2021 | 395 | 0.040 |
Why?
|
| Protein Domains | 1 | 2019 | 140 | 0.040 |
Why?
|
| Sulfonamides | 1 | 2021 | 322 | 0.040 |
Why?
|
| Loss of Heterozygosity | 1 | 2019 | 86 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 1102 | 0.040 |
Why?
|
| SUMO-1 Protein | 1 | 2018 | 16 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2017 | 2033 | 0.040 |
Why?
|
| Sumoylation | 1 | 2018 | 18 | 0.040 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 181 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2018 | 118 | 0.040 |
Why?
|
| Tubulin | 2 | 2009 | 60 | 0.040 |
Why?
|
| Species Specificity | 1 | 2019 | 690 | 0.040 |
Why?
|
| Enterocytes | 1 | 2017 | 26 | 0.040 |
Why?
|
| Cell Self Renewal | 1 | 2017 | 20 | 0.040 |
Why?
|
| Androstenes | 1 | 2017 | 39 | 0.040 |
Why?
|
| Hydrazones | 1 | 2017 | 7 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2019 | 234 | 0.040 |
Why?
|
| I-kappa B Kinase | 1 | 2017 | 41 | 0.040 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2017 | 12 | 0.030 |
Why?
|
| Zebrafish | 1 | 2019 | 323 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2017 | 117 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2018 | 285 | 0.030 |
Why?
|
| Aminopyridines | 1 | 2017 | 41 | 0.030 |
Why?
|
| Benzazepines | 1 | 2017 | 64 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2017 | 96 | 0.030 |
Why?
|
| Benzamides | 1 | 2017 | 237 | 0.030 |
Why?
|
| DNA Polymerase II | 1 | 2016 | 9 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 2009 | 398 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 1066 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 199 | 0.030 |
Why?
|
| Plasmids | 1 | 2017 | 292 | 0.030 |
Why?
|
| Methylation | 1 | 2017 | 276 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2018 | 263 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 181 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2017 | 281 | 0.030 |
Why?
|
| Cricetulus | 1 | 2015 | 127 | 0.030 |
Why?
|
| Quinazolines | 1 | 2017 | 214 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 101 | 0.030 |
Why?
|
| Aged | 4 | 2017 | 19574 | 0.030 |
Why?
|
| Transcription Factor 4 | 1 | 2015 | 4 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2015 | 108 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 243 | 0.030 |
Why?
|
| Endothelium, Corneal | 1 | 2015 | 19 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2017 | 216 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 6847 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2018 | 766 | 0.030 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 103 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2015 | 198 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2017 | 372 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 1500 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2015 | 355 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2014 | 23 | 0.030 |
Why?
|
| GTPase-Activating Proteins | 1 | 2014 | 67 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2017 | 396 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2016 | 282 | 0.030 |
Why?
|
| Cytokines | 1 | 2017 | 817 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2014 | 132 | 0.030 |
Why?
|
| Apoptosis | 1 | 2020 | 1723 | 0.030 |
Why?
|
| Middle Aged | 4 | 2017 | 26555 | 0.030 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2014 | 127 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 268 | 0.030 |
Why?
|
| Genomic Imprinting | 1 | 2012 | 32 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 194 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 1713 | 0.020 |
Why?
|
| Genes, Lethal | 1 | 2011 | 53 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2891 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2012 | 175 | 0.020 |
Why?
|
| Genetic Fitness | 1 | 2011 | 39 | 0.020 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2010 | 11 | 0.020 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2010 | 19 | 0.020 |
Why?
|
| Retinoids | 1 | 2010 | 18 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2011 | 279 | 0.020 |
Why?
|
| Retinoid X Receptors | 1 | 2010 | 39 | 0.020 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2010 | 16 | 0.020 |
Why?
|
| Transcription Initiation Site | 1 | 2010 | 46 | 0.020 |
Why?
|
| Benzoates | 1 | 2010 | 33 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2010 | 48 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 3716 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 694 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 2904 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2017 | 2345 | 0.020 |
Why?
|
| Geography | 1 | 2010 | 229 | 0.020 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 2009 | 18 | 0.020 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2009 | 13 | 0.020 |
Why?
|
| Nanog Homeobox Protein | 1 | 2009 | 7 | 0.020 |
Why?
|
| Antigens, Nuclear | 1 | 2009 | 25 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 2053 | 0.020 |
Why?
|
| Temperature | 1 | 2010 | 404 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2023 | 9399 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2009 | 35 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 3825 | 0.020 |
Why?
|
| RNA Polymerase II | 1 | 2009 | 57 | 0.020 |
Why?
|
| Tretinoin | 1 | 2009 | 130 | 0.020 |
Why?
|
| Microtubules | 1 | 2009 | 129 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2012 | 530 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2008 | 52 | 0.020 |
Why?
|
| Genetic Engineering | 1 | 2008 | 118 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2008 | 234 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 565 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 669 | 0.020 |
Why?
|
| Alleles | 1 | 2010 | 1138 | 0.020 |
Why?
|
| Antigens | 1 | 2008 | 229 | 0.020 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2008 | 114 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 429 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2006 | 391 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2006 | 103 | 0.020 |
Why?
|
| Cefotaxime | 1 | 1985 | 5 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 8436 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 1985 | 91 | 0.010 |
Why?
|
| Metoprolol | 1 | 1984 | 15 | 0.010 |
Why?
|
| Electroporation | 1 | 2004 | 56 | 0.010 |
Why?
|
| Kallikreins | 1 | 1984 | 46 | 0.010 |
Why?
|
| Nervous System | 1 | 2004 | 89 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 803 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1984 | 278 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2006 | 544 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 1985 | 407 | 0.010 |
Why?
|
| Adult | 3 | 2017 | 27147 | 0.010 |
Why?
|
| Phylogeny | 1 | 2004 | 1220 | 0.010 |
Why?
|
| Hypertension | 1 | 1984 | 757 | 0.010 |
Why?
|
| Thrombin Time | 1 | 1985 | 4 | 0.000 |
Why?
|
| Ceftriaxone | 1 | 1985 | 9 | 0.000 |
Why?
|
| Partial Thromboplastin Time | 1 | 1985 | 18 | 0.000 |
Why?
|
| Fibrinogen | 1 | 1985 | 52 | 0.000 |
Why?
|
| 18-Hydroxycorticosterone | 1 | 1984 | 1 | 0.000 |
Why?
|
| 18-Hydroxydesoxycorticosterone | 1 | 1984 | 1 | 0.000 |
Why?
|
| Desoxycorticosterone | 1 | 1984 | 18 | 0.000 |
Why?
|
| Corticosterone | 1 | 1984 | 35 | 0.000 |
Why?
|
| Renin | 1 | 1984 | 67 | 0.000 |
Why?
|
| Aldosterone | 1 | 1984 | 56 | 0.000 |
Why?
|
| Hydrocortisone | 1 | 1984 | 303 | 0.000 |
Why?
|